Emergence of Resistance to Daptomycin during Treatment of Vancomycin-Resistant Enterococcus faecalis Infection
The DOI matches its Crossref record.
Abstract
SIR—Daptomycin is a recently approved antibiotic intended for the treatment of complicated soft-tissue infection. It has in vitro bactericidal activity against gram-positive pathogens [1–5]. We report the case of a 64-year-old woman with cryptogenic cirrhosis who had recently begun hemodialysis with a tunneled intravenous catheter. In May 2004, she presented with hypotension to a community hospital in Indiana and was found to have high-grade bacteremia due to ampicillin-susceptible, vancomycin-resistant Enterococcus faecalis (isolates 1 and 2 in figure 1). Because of her history of penicillin allergy, she was treated with linezolid, and the hemodialysis catheter was removed. Results of culture of the catheter's tip were positive for E. faecalis. Because the patient developed thrombocytopenia, treatment with linezolid was discontinued. The patient was later discharged from the hospital with a prescribed regimen of oral ciprofloxacin. A few days later, she was rehospitalized with fever and blood culture results that were positive for E. faecalis (isolate 3 in figure 1). Treatment with daptomycin and amikacin was initiated in June 2004. The patient's hemodialysis catheter was again removed. Findings of a transesophageal echocardiogram were negative for vegetations. Results of additional blood cultures were negative for E. faecalis, and a new hemodialysis catheter was inserted. The patient was discharged from the hospital with a prescribed regimen of daptomycin 400 mg q48h in addition to amikacin during hemodialysis. PFGE of SmaI-digested chromosomal DNA. Lane 1, isolate 1; lane 2, isolate 2; lane 3, isolate 3; lane 4, isolate 4; lane 5, λ marker. Approximately 2 weeks after the patient was discharged from the hospital, she was rehospitalized with fever and blood culture results that were positive for E. faecalis (isolate 4 in figure 1). Treatment with daptomycin and amikacin was stopped, and treatment with linezolid was restarted. The patient was transferred to a nearby university hospital for ampicillin desensitization. She remained bacteremic, despite receipt of high doses of intravenous ampicillin, and later died. No autopsy was performed. Four E. faecalis isolates were tested: 2 obtained during the initial episode of bacteremia (isolates 1 and 2 in figure 1), 1 isolate obtained just prior to the start of treatment with daptomycin (isolate 3 in figure 1), and 1 isolate obtained during the patient's relapse while she was receiving treatment with daptomycin (isolate 4 in figure 1). Genomic DNA was digested with SmaI, as has been described elsewhere by Matushek et al. [6]. We determined MICs by broth microdilution using Mueller-Hinton broth supplemented with 50 mg/L of Ca2+, according to the guidelines of the NCCLS [7, 8]. Daptomycin was obtained from Cubist Pharmaceuticals. PFGE showed indistinguishable patterns between all 4 isolates of E. faecalis, as seen in figure 1. Isolates 1, 2, and 3 had daptomycin MICs of 1µg/mL, and isolate 4 had an increased daptomycin MIC of 16 µg/mL (nonsusceptibility to daptomycin is defined as an MIC of ⩾8 µg/mL). Susceptibilities of isolates 1 and 4 to vancomycin, linezolid, and synercid were unchanged (data not shown). Daptomycin is considered one of the few therapeutic options for the management of vancomycin-resistant E. faecalis infection [9]. The spontaneous emergence of daptomycin-resistance in vitro has been unsuccessful [10], and, thus far, no cases of resistance in humans have been published. We believe this to be the first case E. faecalis infection reported in which resistance to daptomycin developed while the patient was receiving therapy. Further studies will be done to determine the molecular mechanism of resistance. We thank Irene Dusich for providing the isolates, and we thank Drs. Carolina Ocampo and Richard Yu for providing care for the patient. Financial support. This letter was partially funded by a grant from Cubist pharmaceuticals. Potential conflicts of interest. L.S.M.P. serves as a consultant for Cubist pharmaceuticals. J.P.Q. serves as a consultant and speaker for Cubist pharmaceuticals. K.L.: no conflict.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Genetic Basis for In Vivo Daptomycin Resistance in Enterococci
Arias, C. A., Panesso, D., McGrath, D. M., Qin, X., Mojica, M. F., Miller, C., Diaz, L., Tran, T. T., Rincon, S., Barbu, E. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011138 · Cited by 377
Self-citationEmergence and management of drug-resistant enterococcal infections
Arias, C. A., & Murray, B. E. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.637 · Cited by 294
Tran, T. T., Panesso, D., Mishra, N. N., Mileykovskaya, E., Guan, Z., Munita, J. M., Reyes, J., Diaz, L., Weinstock, G. M., Murray, B. E., et al. (2013) · mBio · doi:10.1128/mbio.00281-13 · Cited by 192
“However, an important emerging clinical problem is the development of DAP resistance during therapy (3, 4).”
BackgroundTran, T. T., Panesso, D., Gao, H., Roh, J. H., Munita, J. M., Reyes, J., Diaz, L., Lobos, E. A., Shamoo, Y., Mishra, N. N., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01454-12 · Cited by 125
Munita, J. M., Panesso, D., Diaz, L., Tran, T. T., Reyes, J., Wanger, A., Murray, B. E., & Arias, C. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00509-12 · Cited by 118
Metadata
- Authors
- Munoz-Price, L. S., Lolans, K., & Quinn, J. P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-08-15
- Volume
- 41
- Issue
- 4
- Pages
- 565-566
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W1975867520
- Cited by
- 156
- References
- 0
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Emergence of Resistance to Daptomycin during Treatment of Vancomycin-Resistant Enterococcus faecalis Infection. https://app.cochat.ai/papers/10.1086/432121
- The paper
- Munoz-Price, L. S., Lolans, K., & Quinn, J. P. (2005). Emergence of Resistance to Daptomycin during Treatment of Vancomycin-Resistant Enterococcus faecalis Infection. Clinical Infectious Diseases. https://doi.org/10.1086/432121
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.